Stock listing
NASDAQ:ONCY Oncolytics Biotech Inc. Stock
Home listing (NASDAQ) of Oncolytics Biotech Inc.
Follow Oncolytics Biotech Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ONCY
$0.425 USD -0.002 (-0.5%)
Close on Oct 30, 2026
- Day range
- $0.405 – $0.430 USDOct 30, 2026
- Volume
- 764,177 sharesOct 30, 2026
- Market cap
- $55.78M USDAt the close on Oct 30, 2026 · price × 131.1M shares outstanding
- 52-week range
- $0.405 – $1.300 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $685,981 USDMedian day 767,889 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ONCY · Home | $0.425 USD | -0.002 (-0.5%) | 764,177 | $0.421 | $0.430 | $0.405 | $0.428 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ONCY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.425 | -0.002 | -0.5% | $0.421 | $0.430 | $0.405 | 764,177 | |
| $0.428 | -0.014 | -3.1% | $0.440 | $0.450 | $0.425 | 606,744 | |
| $0.442 | -0.021 | -4.5% | $0.460 | $0.463 | $0.430 | 2,189,089 | |
| $0.462 | -0.011 | -2.3% | $0.474 | $0.500 | $0.460 | 847,183 | |
| $0.473 | -0.027 | -5.4% | $0.510 | $0.520 | $0.472 | 694,532 | |
| $0.500 | 0.000 | 0.0% | $0.510 | $0.510 | $0.490 | 375,800 | |
| $0.500 | -0.010 | -2.0% | $0.500 | $0.520 | $0.500 | 405,600 | |
| $0.510 | +0.010 | +2.0% | $0.500 | $0.520 | $0.490 | 771,600 | |
| $0.500 | 0.000 | 0.0% | $0.510 | $0.520 | $0.490 | 1,198,100 | |
| $0.500 | 0.000 | 0.0% | $0.510 | $0.550 | $0.490 | 690,500 | |
| $0.500 | -0.050 | -9.1% | $0.550 | $0.550 | $0.490 | 1,336,600 | |
| $0.550 | +0.010 | +1.9% | $0.550 | $0.590 | $0.520 | 1,300,700 | |
| $0.540 | +0.050 | +10.2% | $0.500 | $0.560 | $0.440 | 3,155,000 | |
| $0.490 | +0.020 | +4.3% | $0.490 | $0.500 | $0.450 | 4,202,500 | |
| $0.470 | -0.090 | -16.1% | $0.570 | $0.590 | $0.440 | 3,317,400 | |
| $0.560 | +0.020 | +3.7% | $0.550 | $0.570 | $0.530 | 1,459,000 | |
| $0.540 | -0.060 | -10.0% | $0.600 | $0.610 | $0.540 | 1,122,200 | |
| $0.600 | 0.000 | 0.0% | $0.590 | $0.610 | $0.580 | 669,000 | |
| $0.600 | 0.000 | 0.0% | $0.600 | $0.610 | $0.580 | 858,500 | |
| $0.600 | -0.030 | -4.8% | $0.640 | $0.640 | $0.580 | 1,936,400 | |
| $0.630 | -0.010 | -1.6% | $0.650 | $0.650 | $0.620 | 609,300 | |
| $0.640 | -0.030 | -4.5% | $0.670 | $0.680 | $0.630 | 689,800 | |
| $0.670 | 0.000 | 0.0% | $0.680 | $0.680 | $0.650 | 867,000 | |
| $0.670 | +0.010 | +1.5% | $0.670 | $0.680 | $0.660 | 779,000 | |
| $0.660 | -0.020 | -2.9% | $0.680 | $0.720 | $0.660 | 1,129,200 | |
| $0.680 | 0.000 | 0.0% | $0.690 | $0.690 | $0.670 | 822,000 | |
| $0.680 | 0.000 | 0.0% | $0.680 | $0.690 | $0.640 | 1,213,700 | |
| $0.680 | -0.030 | -4.2% | $0.730 | $0.730 | $0.660 | 1,890,900 | |
| $0.710 | -0.060 | -7.8% | $0.760 | $0.780 | $0.710 | 2,075,200 | |
| $0.770 | 0.000 | 0.0% | $0.770 | $0.790 | $0.760 | 693,300 | |
| $0.770 | 0.000 | 0.0% | $0.780 | $0.780 | $0.760 | 491,500 | |
| $0.770 | 0.000 | 0.0% | $0.780 | $0.800 | $0.770 | 594,200 | |
| $0.770 | -0.010 | -1.3% | $0.780 | $0.800 | $0.760 | 958,300 | |
| $0.780 | -0.030 | -3.7% | $0.830 | $0.840 | $0.780 | 903,100 | |
| $0.810 | +0.060 | +8.0% | $0.760 | $0.850 | $0.760 | 1,399,400 | |
| $0.750 | -0.020 | -2.6% | $0.770 | $0.770 | $0.730 | 1,198,300 | |
| $0.770 | -0.030 | -3.8% | $0.790 | $0.830 | $0.760 | 3,787,600 | |
| $0.800 | -0.010 | -1.2% | $0.800 | $0.830 | $0.790 | 741,300 | |
| $0.810 | -0.030 | -3.6% | $0.830 | $0.840 | $0.790 | 1,140,800 | |
| $0.840 | -0.020 | -2.3% | $0.840 | $0.850 | $0.830 | 463,700 | |
| $0.860 | -0.020 | -2.3% | $0.880 | $0.890 | $0.840 | 582,800 | |
| $0.880 | +0.040 | +4.8% | $0.850 | $0.910 | $0.840 | 1,585,400 | |
| $0.840 | 0.000 | 0.0% | $0.830 | $0.860 | $0.830 | 435,100 | |
| $0.840 | -0.020 | -2.3% | $0.850 | $0.870 | $0.830 | 428,900 | |
| $0.860 | +0.010 | +1.2% | $0.840 | $0.860 | $0.820 | 673,100 | |
| $0.850 | -0.010 | -1.2% | $0.860 | $0.870 | $0.840 | 569,100 | |
| $0.860 | 0.000 | 0.0% | $0.860 | $0.870 | $0.840 | 410,100 | |
| $0.860 | +0.020 | +2.4% | $0.850 | $0.870 | $0.840 | 775,300 | |
| $0.840 | 0.000 | 0.0% | $0.850 | $0.850 | $0.800 | 486,400 | |
| $0.840 | +0.040 | +5.0% | $0.800 | $0.850 | $0.800 | 539,900 | |
| $0.800 | -0.030 | -3.6% | $0.830 | $0.830 | $0.790 | 682,000 | |
| $0.830 | -0.010 | -1.2% | $0.840 | $0.860 | $0.830 | 608,700 | |
| $0.840 | +0.020 | +2.4% | $0.820 | $0.860 | $0.820 | 798,700 | |
| $0.820 | -0.010 | -1.2% | $0.840 | $0.850 | $0.810 | 523,100 | |
| $0.830 | +0.030 | +3.7% | $0.800 | $0.850 | $0.780 | 1,128,000 | |
| $0.800 | -0.020 | -2.4% | $0.840 | $0.840 | $0.800 | 586,900 | |
| $0.820 | 0.000 | 0.0% | $0.800 | $0.830 | $0.790 | 716,000 | |
| $0.820 | +0.020 | +2.5% | $0.800 | $0.830 | $0.780 | 673,000 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.810 | $0.760 | 813,600 | |
| $0.800 | 0.000 | 0.0% | $0.800 | $0.820 | $0.790 | 571,300 | |
| $0.800 | 0.000 | 0.0% | $0.790 | $0.820 | $0.790 | 555,300 | |
| $0.800 | -0.010 | -1.2% | $0.800 | $0.810 | $0.780 | 431,300 | |
| $0.810 | +0.030 | +3.8% | $0.800 | $0.820 | $0.780 | 578,600 | |
| $0.780 | +0.030 | +4.0% | $0.750 | $0.790 | $0.750 | 746,900 | |
| $0.750 | 0.000 | 0.0% | $0.770 | $0.770 | $0.740 | 834,900 | |
| $0.750 | 0.000 | 0.0% | $0.760 | $0.770 | $0.730 | 995,800 |
- Ticker
- NASDAQ:ONCY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 27 slides
Calls
Replays
Oncolytics Biotech (NASDAQ:ONCY) Q2 2025 Earnings Call
Thu, Aug 07, 2025 · 4:30 PM ET
Watch TranscriptOncolytics Biotech (NASDAQ:ONCY) Q1 2025 Earnings Call
Wed, May 14, 2025 · 4:30 PM ET
Watch TranscriptOncolytics Biotech (NASDAQ:ONCY) Q4 2024 Earnings Call
Fri, Mar 07, 2025 · 8:30 AM ET
Watch Transcript
Latest news
Oncolytics Biotech® Reports Strong Durability and Survival Data in Anal Cancer, Positioning Pelareorep as Potential Backbone Immunotherapy Across HPV-Driven Cancers
Oct 27, 2026
Closed $0.462 (-2.3%) on Oct 27, 2026
Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
Oct 20, 2026
Closed $0.50 (0.0%) on Oct 20, 2026
Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment
Oct 14, 2026
Closed $0.54 (+10.2%) on Oct 14, 2026
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
Oct 12, 2026
Closed $0.49 (+4.3%) on Oct 13, 2026
Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
Sep 29, 2026
Closed $0.67 (+1.5%) on Sep 29, 2026
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
Sep 28, 2026
Closed $0.66 (-2.9%) on Sep 28, 2026
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
Sep 10, 2026
Closed $0.77 (-3.8%) on Sep 10, 2026
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
Aug 18, 2026
Closed $0.84 (+2.4%) on Aug 18, 2026
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Jul 20, 2026
Closed $0.85 (0.0%) on Jul 20, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 27 slides · August 2026
Investor Presentation (June 2026)
Investor deck · 27 slides · June 2026
Investor Presentation (April 2026)
Investor deck · 26 slides · April 2026
Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
Oncolytics Biotech Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 307 in all · newest Oct 27, 2026 · oldest 2016
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 7, 2025
- Decks
- 22 decks · latest August 2026
Where Oncolytics Biotech Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ONCY · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ONCY | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Oncolytics Biotech Inc.